
zzso zzso zzso zzso is an oral zzso zzso zzso zzso inhibitor that targets zzso zzso has greater affinity and is a more selective inhibitor of zzso zzso 1, zzso and zzso zzso and zzso than both zzso and zzso It has encouraging efficacy and safety data in Phase II trials for zzso zzso cell zzso and advanced zzso cancer zzso It is now being investigated in two Phase III trials in zzso zzso cell zzso and in Phase II trials in a range of tumor zzso These trials will determine whether zzso is an effective and safe zzso zzso 

